Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
The company has now received the renewed GMP (Good Manufacturing Practices) certificate thereby confirming the successful closure of the inspection
Mucormycosis drug AmphoTLC will be imported from Taiwan by Stelis Biopharma Private Limited (Stelis), the biotech arm of Strides group, and will be launched and distributed in India immediately by Strides
Subscribe To Our Newsletter & Stay Updated
